Abstract
Gastric adenosquamous carcinoma (GASC) is a rare subtype of gastric cancer. Research on GASC treatment is limited, and its outcome is usually poor. We investigated the clinical features, immunoprofile of GASC and determined the optimal treatment modality for these patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have